Pharmaceutical Business review

Endologix receives approval to launch Powerlink System in Japan

Endologix’s Powerlink System is an endoluminal stent graft for treating abdominal aortic aneurysms.

Paul McCormick, president and CEO of Endologix, said: “We will begin by shipping an initial stocking order in February to our Japanese distributor Cosmotec and expect that the first Powerlink System implants will be performed at the Tokyo Medical University Hospital.”